Hameeteman W - Search Results

1

Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice.

Witteman BP, Strijkers R, de Vries E, Toemen L, Conchillo JM, Hameeteman W, Dagnelie PC, Koek GH, Bouvy ND. Witteman BP, et al. Among authors: hameeteman w. Surg Endosc. 2012 Nov;26(11):3307-15. doi: 10.1007/s00464-012-2324-2. Epub 2012 May 31. Surg Endosc. 2012. PMID: 22648098 Free PMC article.

2

Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy.

Sanduleanu S, De Bruïne A, Stridsberg M, Jonkers D, Biemond I, Hameeteman W, Lundqvist G, Stockbrügger RW. Sanduleanu S, et al. Among authors: hameeteman w. Eur J Clin Invest. 2001 Sep;31(9):802-11. doi: 10.1046/j.1365-2362.2001.00890.x. Eur J Clin Invest. 2001. PMID: 11589723

3

Inflammatory cloacogenic polyp: diagnostic features by confocal endomicroscopy.

Sanduleanu S, Driessen A, Hameeteman W, van Gemert W, de Bruïne A, Masclee A. Sanduleanu S, et al. Among authors: hameeteman w. Gastrointest Endosc. 2009 Mar;69(3 Pt 1):595-8. doi: 10.1016/j.gie.2008.04.013. Epub 2008 Jul 26. Gastrointest Endosc. 2009. PMID: 18656863 No abstract available.

4

The spectrum of columnar-lined esophagus--Barrett's esophagus.

Tytgat GN, Hameeteman W, Onstenk R, Schotborg R. Tytgat GN, et al. Among authors: hameeteman w. Endoscopy. 1989 Jul;21(4):177-85. doi: 10.1055/s-2007-1012937. Endoscopy. 1989. PMID: 2673752 Review. No abstract available.

5

Barrett's oesophagus.

Bartlesman JF, Hameeteman W, Tÿtgat GN. Bartlesman JF, et al. Among authors: hameeteman w. Eur J Cancer Prev. 1992 Jun;1(4):323-5. doi: 10.1097/00008469-199206000-00008. Eur J Cancer Prev. 1992. PMID: 1467782

6

Cost effectiveness of medical versus surgical treatment in patients with severe or refractory gastroesophageal reflux disease in the Netherlands.

Van Den Boom G, Go PM, Hameeteman W, Dallemagne B, Ament AJ. Van Den Boom G, et al. Among authors: hameeteman w. Scand J Gastroenterol. 1996 Jan;31(1):1-9. doi: 10.3109/00365529609031619. Scand J Gastroenterol. 1996. PMID: 8927933 Free article.

7

Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study.

Sanduleanu S, Stridsberg M, Jonkers D, Hameeteman W, Biemond I, Lundqvist G, Lamers C, Stockbrügger RW. Sanduleanu S, et al. Among authors: hameeteman w. Aliment Pharmacol Ther. 1999 Feb;13(2):145-53. doi: 10.1046/j.1365-2036.1999.00466.x. Aliment Pharmacol Ther. 1999. PMID: 10102943 Free article.

8

A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery.

Schouten R, Rijs CS, Bouvy ND, Hameeteman W, Koek GH, Janssen IM, Greve JW. Schouten R, et al. Among authors: hameeteman w. Ann Surg. 2010 Feb;251(2):236-43. doi: 10.1097/SLA.0b013e3181bdfbff. Ann Surg. 2010. PMID: 19858703 Clinical Trial.

9

Plasma intestinal fatty acid-binding protein fails to predict endoscopic disease activity in inflammatory bowel disease patients.

Bodelier AG, Pierik MJ, Lenaerts K, de Boer E, Olde Damink SW, Hameeteman WM, Masclee AA, Jonkers DM. Bodelier AG, et al. Among authors: hameeteman wm. Eur J Gastroenterol Hepatol. 2016 Jul;28(7):807-13. doi: 10.1097/MEG.0000000000000616. Eur J Gastroenterol Hepatol. 2016. PMID: 26919325

10

Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa.

Sanduleanu S, Jonkers D, De Bruine A, Hameeteman W, Stockbrügger RW. Sanduleanu S, et al. Among authors: hameeteman w. Aliment Pharmacol Ther. 2001 Mar;15(3):379-88. doi: 10.1046/j.1365-2036.2001.00888.x. Aliment Pharmacol Ther. 2001. PMID: 11207513 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results